Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 AHA科学声明：激素疗法治疗激素依赖性癌症（乳腺癌和前列腺癌）对心血管系统的影响

2021-06-01 美国心脏协会 Circ Genom Precis Med

妇瘤乳腺肿瘤泌尿生殖系肿瘤激素依赖性癌症

激素依赖性癌症（乳腺癌和前列腺癌）分别是女性和男性中最常见的非皮肤恶性肿瘤。作为治疗两种癌症的支柱的激素（内分泌相关）疗法可提高生存率，但也会增加幸存者的心血管发病率和死亡率。

中文标题：

2021 AHA科学声明：激素疗法治疗激素依赖性癌症（乳腺癌和前列腺癌）对心血管系统的影响

英文标题：

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association

发布机构：

美国心脏协会

发布日期：

2021-06-01

简要介绍：

激素依赖性癌症（乳腺癌和前列腺癌）分别是女性和男性中最常见的非皮肤恶性肿瘤。作为治疗两种癌症的支柱的激素（内分泌相关）疗法可提高生存率，但也会增加幸存者的心血管发病率和死亡率。该共识声明描述了与用于治疗乳腺癌和前列腺癌的特定激素疗法相关的风险，并提供了一种预防和检测不良心血管结局的循证方法。强调了不确定的领域，包括不同持续时间的激素治疗对心血管的影响，与新一代更强化激素治疗组合相关的心血管风险，以及影响不同种族/民族个体的特定心血管风险。最后，强调在积极治疗期间和之后使用多学科方法来实施生活方式和药物策略以进行管理和降低风险。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 AHA科学声明：激素疗法治疗激素依赖性癌症（乳腺癌和前列腺癌）对心血管系统的影响.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5397d1c00225e888, title=2021 AHA科学声明：激素疗法治疗激素依赖性癌症（乳腺癌和前列腺癌）对心血管系统的影响, enTitle=Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association, guiderFrom=Circ Genom Precis Med, authorId=0, author=, summary=激素依赖性癌症（乳腺癌和前列腺癌）分别是女性和男性中最常见的非皮肤恶性肿瘤。作为治疗两种癌症的支柱的激素（内分泌相关）疗法可提高生存率，但也会增加幸存者的心血管发病率和死亡率。, cover=https://img.medsci.cn/2021118/1636379554826_1608702.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会（AHA，American Heart Association）是心脏病学领域比较正要的学会之一，致力于心脏病和卒中的预防与治疗，提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等，有官方杂志《美国心脏协会杂志》，提供心血管疾病和卒中相关的指南及专家共识，更新的比较快。, copyright=0, guiderPublishedTime=Tue Jun 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>激素依赖性癌症（乳腺癌和前列腺癌）分别是女性和男性中最常见的非皮肤恶性肿瘤。作为治疗两种癌症的支柱的激素（内分泌相关）疗法可提高生存率，但也会增加幸存者的心血管发病率和死亡率。该共识声明描述了与用于治疗乳腺癌和前列腺癌的特定激素疗法相关的风险，并提供了一种预防和检测不良心血管结局的循证方法。强调了不确定的领域，包括不同持续时间的激素治疗对心血管的影响，与新一代更强化激素治疗组合相关的心血管风险，以及影响不同种族/民族个体的特定心血管风险。最后，强调在积极治疗期间和之后使用多学科方法来实施生活方式和药物策略以进行管理和降低风险。</p>, tagList=[TagDto(tagId=117297, tagName=妇瘤乳腺肿瘤), TagDto(tagId=117298, tagName=泌尿生殖系肿瘤), TagDto(tagId=117299, tagName=激素依赖性癌症)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3438, appHits=90, showAppHits=0, pcHits=655, showPcHits=3348, likes=1, shares=33, comments=7, approvalStatus=1, publishedTime=Tue Nov 16 23:57:01 CST 2021, publishedTimeString=2021-06-01, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=dajiong, createdTime=Mon Nov 08 23:40:37 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 03:43:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHA科学声明：激素疗法治疗激素依赖性癌症（乳腺癌和前列腺癌）对心血管系统的影响.pdf)])
2021 AHA科学声明：激素疗法治疗激素依赖性癌症（乳腺癌和前列腺癌）对心血管系统的影响.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1068542, encodeId=335410685429d, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c455700474, createdName=ms3000000640981149, createdTime=Tue Nov 09 11:19:40 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068496, encodeId=ecad106849626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e55700289, createdName=ms2000000153158115, createdTime=Tue Nov 09 10:35:37 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068412, encodeId=3e4e106841298, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Tue Nov 09 09:24:49 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068362, encodeId=c26610683622a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 09 06:53:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068339, encodeId=87c1106833906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211108/e2bd4fbd41934073b5b4642cc3ed6be5/e025ada6c52248628122bf623088bde7.jpg, createdBy=6ee35699707, createdName=王每斯, createdTime=Mon Nov 08 23:55:00 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-09 ms3000000640981149

    收益了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1068542, encodeId=335410685429d, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c455700474, createdName=ms3000000640981149, createdTime=Tue Nov 09 11:19:40 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068496, encodeId=ecad106849626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e55700289, createdName=ms2000000153158115, createdTime=Tue Nov 09 10:35:37 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068412, encodeId=3e4e106841298, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Tue Nov 09 09:24:49 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068362, encodeId=c26610683622a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 09 06:53:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068339, encodeId=87c1106833906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211108/e2bd4fbd41934073b5b4642cc3ed6be5/e025ada6c52248628122bf623088bde7.jpg, createdBy=6ee35699707, createdName=王每斯, createdTime=Mon Nov 08 23:55:00 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-09 ms2000000153158115

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1068542, encodeId=335410685429d, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c455700474, createdName=ms3000000640981149, createdTime=Tue Nov 09 11:19:40 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068496, encodeId=ecad106849626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e55700289, createdName=ms2000000153158115, createdTime=Tue Nov 09 10:35:37 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068412, encodeId=3e4e106841298, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Tue Nov 09 09:24:49 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068362, encodeId=c26610683622a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 09 06:53:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068339, encodeId=87c1106833906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211108/e2bd4fbd41934073b5b4642cc3ed6be5/e025ada6c52248628122bf623088bde7.jpg, createdBy=6ee35699707, createdName=王每斯, createdTime=Mon Nov 08 23:55:00 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-09 谷芬

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1068542, encodeId=335410685429d, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c455700474, createdName=ms3000000640981149, createdTime=Tue Nov 09 11:19:40 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068496, encodeId=ecad106849626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e55700289, createdName=ms2000000153158115, createdTime=Tue Nov 09 10:35:37 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068412, encodeId=3e4e106841298, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Tue Nov 09 09:24:49 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068362, encodeId=c26610683622a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 09 06:53:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068339, encodeId=87c1106833906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211108/e2bd4fbd41934073b5b4642cc3ed6be5/e025ada6c52248628122bf623088bde7.jpg, createdBy=6ee35699707, createdName=王每斯, createdTime=Mon Nov 08 23:55:00 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-09 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1068542, encodeId=335410685429d, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c455700474, createdName=ms3000000640981149, createdTime=Tue Nov 09 11:19:40 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068496, encodeId=ecad106849626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51e55700289, createdName=ms2000000153158115, createdTime=Tue Nov 09 10:35:37 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068412, encodeId=3e4e106841298, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Tue Nov 09 09:24:49 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068362, encodeId=c26610683622a, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Tue Nov 09 06:53:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068339, encodeId=87c1106833906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211108/e2bd4fbd41934073b5b4642cc3ed6be5/e025ada6c52248628122bf623088bde7.jpg, createdBy=6ee35699707, createdName=王每斯, createdTime=Mon Nov 08 23:55:00 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-08 王每斯

    学习了

    0

Baidu
map
Baidu
map
Baidu
map